Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.
about
The effects of antimuscarinic treatment on the cognition of spinal cord injured individuals with neurogenic lower urinary tract dysfunction: a prospective controlled before-and-after study.Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients.An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.Examination and Estimation of Anticholinergic Burden: Current Trends and Implications for Future Research.A Novel Scale Linking Potency and Dosage to Estimate Anticholinergic Exposure in Older Adults: the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale.Asthma in the elderly and late-onset adult asthma.Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing.Persistent impairment in working memory following severe hyperglycemia in newly diagnosed type 2 diabetes.Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study.Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales.Medicines management in community settings: The role of the nurse.Role of anticholinergic burden in primary care patients with first cognitive complaints.The Screening of Anticholinergic Accumulation by Traditional Chinese Medicine.Anticholinergic Exposure in a Cohort of Adults Aged 80 years and Over: Associations of the MARANTE Scale with Mortality and Hospitalization.Anticholinergic burden and 1-year mortality among older patients discharged from acute care hospital.Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients.Decision Tree for Early Detection of Cognitive Impairment by Community Pharmacists
P2860
Q38635232-D82D0917-2262-455C-A675-77B2E34F2D91Q38672176-8057173E-36B4-435D-97F0-A2B4AF0288B5Q38796735-19CC500B-D522-4F01-88B2-D6EC13CBA51DQ38886942-604A55F1-C0E8-424D-B922-6282F8CF8217Q39019058-48E6216B-545D-4F28-A194-DD1653F9F395Q39444012-C46DDFB1-36FB-4FD5-BF7F-C95FD64CF929Q39487718-FFA0A79C-972B-4651-BB13-6D78B5CEC7AEQ47141054-05A68C14-C58F-4EEE-8E1D-02201344CB3DQ47386779-558330EE-931E-4665-9ECD-A412049C4E85Q47559523-9572DD1D-E183-41B7-BB27-57EE45584558Q47569297-F1D30CA9-A242-491C-91E7-0998BB543177Q47723092-2197EBE0-8C89-46EB-BE00-C2F49D141A57Q47901868-8F6E46A9-D4C9-4D3A-BB55-7DF794CF688EQ47913293-5D543E39-DE23-4D9B-BBAC-4BC8F42AEFB8Q48324819-61BB35A9-3C23-48A8-A69D-188D9E0EA9EBQ55432805-A58062B0-8BEC-48B8-A0D6-1BE9E8FF816FQ58699041-412027A8-DF16-4EA3-94BE-84CF68A883AF
P2860
Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Anticholinergic drugs and nega ...... sibility to clinical evidence.
@en
type
label
Anticholinergic drugs and nega ...... sibility to clinical evidence.
@en
prefLabel
Anticholinergic drugs and nega ...... sibility to clinical evidence.
@en
P2093
P2860
P50
P1476
Anticholinergic drugs and nega ...... usibility to clinical evidence
@en
P2093
Agnese Collamati
Anna Maria Martone
Francesco Landi
Michela Celi
Vincenzo Brandi
P2860
P2888
P356
10.1007/S40520-015-0359-7
P577
2015-05-01T00:00:00Z
P6179
1033629518